loading...| Preferred Name |
clofazimine |
|
| Synonyms |
C27H22Cl2N4 clofazimine 3-(p-chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine clofazimina 3-(p-chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-phenazine N,5-bis(4-chlorophenyl)-3-[(propan-2-yl)imino]-3,5-dihydrophenazin-2-amine clofaziminum (4-Chloro-phenyl)-[5-(4-chloro-phenyl)-3-isopropylimino-3,5-dihydro-phenazin-2-yl]-amine N,5-bis(4-chlorophenyl)-3-(isopropylimino)-3,5-dihydrophenazin-2-amine |
|
| ID |
http://purl.obolibrary.org/obo/CHEBI_3749 |
|
| altId |
CHEBI:355347 |
|
| ATCCode |
J04BA01 |
|
| CASRN |
2030-63-9 |
|
| DBBrand |
lampren lamprene |
|
| DBname |
clofazimine |
|
| DBSynonym |
chlofazimine clofaziminum [inn-latin] clofazimina [inn-spanish] |
|
| Definition |
3-Isopropylimino-3,5-dihydro-phenazine in which the hydrogen at position 5 is substituted substituted by a 4-chlorophenyl group, and that at position 2 is substituted by a (4-chlorophenyl)amino group. A dark red crystalline solid, clofazimine is an antimycobacterial and is one of the main drugs used for the treatment of multi-bacillary leprosy. However, it can cause red/brown discolouration of the skin, so other treatments are often preferred in light-skinned patients. |
|
| has effect |
http://purl.obolibrary.org/obo/OAE_0000388 http://purl.obolibrary.org/obo/OAE_0001098 http://purl.obolibrary.org/obo/OAE_0000377 http://purl.obolibrary.org/obo/OAE_0000373 http://purl.obolibrary.org/obo/OAE_0000210 http://purl.obolibrary.org/obo/OAE_0000600 http://purl.obolibrary.org/obo/OAE_0000920 http://purl.obolibrary.org/obo/OAE_0000601 http://purl.obolibrary.org/obo/OAE_0000533 http://purl.obolibrary.org/obo/OAE_0000034 http://purl.obolibrary.org/obo/OAE_0000866 http://purl.obolibrary.org/obo/OAE_0000401 http://purl.obolibrary.org/obo/OAE_0000468 http://purl.obolibrary.org/obo/OAE_0000602 http://purl.obolibrary.org/obo/OAE_0001147 http://purl.obolibrary.org/obo/OAE_0000396 http://purl.obolibrary.org/obo/OAE_0000362 http://purl.obolibrary.org/obo/OAE_0000514 http://purl.obolibrary.org/obo/OAE_0000374 |
|
| has pharmacological target | ||
| has role |
http://purl.obolibrary.org/obo/CHEBI_35475 |
|
| InChI |
InChI=1S/C27H22Cl2N4/c1-17(2)30-24-16-27-25(15-23(24)31-20-11-7-18(28)8-12-20)32-22-5-3-4-6-26(22)33(27)21-13-9-19(29)10-14-21/h3-17,31H,1-2H3/b30-24+ InChI=1S/C27H22Cl2N4/c1-17(2)30-24-16-27-25(15-23(24)31-20-11-7-18(28)8-12-20)32-22-5-3-4-6-26(22)33(27)21-13-9-19(29)10-14-21/h3-17,31H,1-2H3 |
|
| InChIKey |
InChIKey=WDQPAMHFFCXSNU-UHFFFAOYSA-N InChIKey=WDQPAMHFFCXSNU-BGABXYSRSA-N |
|
| inhibits |
http://purl.obolibrary.org/obo/dinto_3914 http://purl.obolibrary.org/obo/dinto_0901 |
|
| is metabolised by | ||
| label |
clofazimine |
|
| prefixIRI |
obo2:CHEBI_3749 |
|
| prefLabel |
clofazimine |
|
| related with | ||
| SMILES |
CC(C)N=c1cc2n(-c3ccc(Cl)cc3)c3ccccc3nc2cc1Nc1ccc(Cl)cc1 CC(C)N=C1C=C2N(C3=CC=C(Cl)C=C3)C3=C(C=CC=C3)N=C2C=C1NC1=CC=C(Cl)C=C1 |
|
| Synonym |
C27H22Cl2N4 clofazimine 3-(p-chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine clofazimina 3-(p-chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-phenazine N,5-bis(4-chlorophenyl)-3-[(propan-2-yl)imino]-3,5-dihydrophenazin-2-amine clofaziminum (4-Chloro-phenyl)-[5-(4-chloro-phenyl)-3-isopropylimino-3,5-dihydro-phenazin-2-yl]-amine N,5-bis(4-chlorophenyl)-3-(isopropylimino)-3,5-dihydrophenazin-2-amine |
|
| xref |
ChEBI:3749 Beilstein:8168151 DrugBank:DB00845 RxList:http://www.rxlist.com/cgi/generic3/clofazimine.htm ChEMBL:17210775 Wikipedia:http://en.wikipedia.org/wiki/Clofazimine Drugs.com:http://www.drugs.com/cons/clofazimine.html Patent:US2948726 CASRN:2030-63-9 ChEMBL:893291 KEGG COMPOUND:C06915 ChEMBL:3279207 PharmGKB:PA164748759 KEGG DRUG:D00278 |
|
| subClassOf |